Rhumbline Advisers Has $7.34 Million Position in Privia Health Group, Inc. $PRVA

Rhumbline Advisers boosted its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 8.4% during the second quarter, HoldingsChannel.com reports. The firm owned 319,160 shares of the company’s stock after acquiring an additional 24,807 shares during the period. Rhumbline Advisers’ holdings in Privia Health Group were worth $7,341,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Privia Health Group by 180.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,633,040 shares of the company’s stock valued at $59,112,000 after buying an additional 1,693,870 shares during the period. Nuveen LLC purchased a new stake in shares of Privia Health Group during the first quarter worth $26,899,000. Geode Capital Management LLC raised its holdings in shares of Privia Health Group by 6.3% during the second quarter. Geode Capital Management LLC now owns 2,655,569 shares of the company’s stock worth $61,086,000 after acquiring an additional 158,521 shares in the last quarter. Cinctive Capital Management LP boosted its position in Privia Health Group by 82.2% during the first quarter. Cinctive Capital Management LP now owns 253,783 shares of the company’s stock valued at $5,697,000 after purchasing an additional 114,478 shares during the last quarter. Finally, Royal Bank of Canada grew its stake in Privia Health Group by 63.5% in the first quarter. Royal Bank of Canada now owns 245,633 shares of the company’s stock valued at $5,514,000 after purchasing an additional 95,371 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Truist Financial reaffirmed a “buy” rating and issued a $31.00 target price (up from $30.00) on shares of Privia Health Group in a research report on Monday, November 10th. Citigroup reissued an “outperform” rating on shares of Privia Health Group in a research note on Friday, August 29th. Piper Sandler dropped their price objective on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a report on Monday, August 11th. Citizens Jmp lifted their target price on shares of Privia Health Group from $30.00 to $31.00 and gave the company a “market outperform” rating in a research note on Friday, November 7th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Privia Health Group from $32.00 to $33.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Privia Health Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $30.00.

Privia Health Group Stock Performance

PRVA opened at $24.00 on Wednesday. The firm has a market cap of $2.95 billion, a P/E ratio of 184.63, a price-to-earnings-growth ratio of 4.01 and a beta of 0.83. The business has a 50 day moving average price of $24.44 and a 200 day moving average price of $22.75. Privia Health Group, Inc. has a twelve month low of $18.77 and a twelve month high of $26.51.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings results on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%.The company had revenue of $213.61 million for the quarter. As a group, analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.